Login

Forgot password?
Sign up today and your first download is free.
REGISTER

Congress

March 18, 2020 | Daily News

Large self-insured employers who praised Treasury for quickly clarifying that they can offer coronavirus-related services pre-deductible for consumers with high-deductible health plans linked to health savings accounts are also pushing legislation to codify that guidance and allow telehealth services to be covered for any visits, not just those related to coronavirus.

March 17, 2020 | Daily News

Senate Minority Leader Chuck Schumer (D-NY) sent a letter to his colleagues on Tuesday (March 17) calling for additional funding for hospital providers to help manage their response to COVID-19 as Congress prepares a third legislative package to tackle the pandemic.

March 16, 2020 | Daily News

Hospitals are asking Congress to remove the Medicare sequester at least for the duration of the COVID-19 pandemic and providers separately are asking for at least $1 billion in direct funding in COVID-19 legislation to cover a number of pandemic expenses including training for and implementing telemedicine.

March 16, 2020 | Daily News

The hospitals and insurance companies wrapped up in the surprise billing debate on Capitol Hill say they will ban surprise, out-of-network bills for care related to coronavirus.

March 12, 2020 | Daily News

Rep. Mark Pocan (D-WI) urged FDA chief Stephen Hahn to be honest with the public about the number of people that can be tested per day for coronavirus, coming as Hahn and other members of the White House’s Coronavirus Task Force tout the large number of diagnostic test that are being sent out to public health labs and hospitals.

March 11, 2020 | Daily News

The House Energy & Commerce health subcommittee on Wednesday (March 11) unanimously approved three bills that would strengthen patient protections for Medicare and Medicaid beneficiaries.

March 11, 2020 | Daily News

House Energy & Commerce Committee leaders from both parties have requested FDA brief them by March 23 on the effect the coronavirus outbreak has had on the drug and device supply chain and on how the agency plans to combat potential shortages.

March 11, 2020 | Daily News

Sen. Mark Warner (D-VA) and HHS Secretary Alex Azar both sounded the alarm that the United States could face drug shortages during the outbreak of the novel coronavirus, due to our reliance on foreign-made pharmaceutical products and supplies.

March 10, 2020 | Daily News

Republican senators and administration officials are pushing for a vote this week on bipartisan legislation that would shield certain manufacturers and distributors of masks from lawsuits during the coronavirus outbreak.

March 10, 2020 | Daily News

The House Energy & Commerce health subcommittee will mark up a wide-ranging slate of bills on Wednesday (March 11), committee Chair Frank Pallone (D-NJ) and subcommittee Chair Anna Eshoo (D-CA) announced Monday.

March 06, 2020 | Daily News

Democratic senators are demanding HHS immediately reverse actions that have undermined the Affordable Care Act and other policies that could impede consumers’ ability to get coverage amid the coronavirus outbreak, and pledge to ensure any coronavirus vaccine will be affordable.

March 06, 2020 | Daily News

House Energy & Commerce Committee leaders ask FDA to share information about the types of temporary withdrawals it is seeing in the generic drug market and how the agency is monitoring the marketing status of generic drugs.

March 06, 2020 | Daily News

FDA plans to reopen the public docket for its May 2019 cannabidiol hearing so that stakeholders can share relevant data on CBD, agency chief Stephen Hahn said in a Thursday (March 5) press release, which provided an overview of FDA’s current work in the area.

March 06, 2020 | Daily News

By next week, public health labs and hospitals should have enough COVID-19 diagnostic test kits to conduct up to 4 million tests, HHS Secretary Alex Azar told reporters Friday (March 6), shortly after President Donald Trump signed into law an emergency coronavirus supplemental funding bill that gives $61 million to FDA for medical product shortage response efforts and that waives certain Medicare telehealth restrictions during the COVID-19 public health emergency.

March 03, 2020 | Daily News

CMS plans to issue this spring several overdue Medicaid guidance documents meant to help states tackle the nation’s drug overdose crisis, an agency official told lawmakers Tuesday (March 3) in response to questions triggered by an Inside Health Policy investigation of the Trump administration’s lagging implementation of a major opioid law.

February 28, 2020 | Daily News

Despite objections from the Trump administration, the House on Friday (Feb. 28) passed Rep. Frank Pallone’s (D-NJ) vaping bill that would ban all characterizing e-cigarette flavors, allow FDA to collect user fees from all classes of tobacco products and increase the total amount of user fees collected by $100 million.

February 28, 2020 | Daily News

Reps. Tim Ryan (D-OH) and Bill Posey (R-FL) introduced legislation to protect U.S. consumers from potentially contaminated foreign pharmaceuticals by giving FDA authority to require black box warnings on products that are manufactured without adequate supervision.

February 26, 2020 | Daily News

HHS Secretary Alex Azar stressed Wednesday (Feb. 26) that HHS will not approve any state Medicaid waivers that would block grant coverage for pregnant women, low-income parents, children or people with disabilities.

February 26, 2020 | Daily News

Senate appropriators on Tuesday (Feb. 25) grilled HHS Secretary Alex Azar on whether the White House’s $2.5 billion supplemental funding request is enough to respond to the coronavirus outbreak and to beef up the U.S. supply of masks, ventilators and other personal protective equipment given other cuts sought by the White House.

February 26, 2020 | Daily News

Days before HHS requested $2.5 billion from Congress to develop drugs and equipment for the coronavirus response, a group of 46 House Democrats cautioned the administration against awarding companies exclusive licenses for coronavirus drugs invented with taxpayer money, and they said the administration “must use every tool of the federal government to ensure a coronavirus vaccine is affordable and accessible.”  

Pages